Literature DB >> 18480234

Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the newVidia analyzer system.

Adriana Calderaro1, Giovanna Piccolo, Simona Peruzzi, Chiara Gorrini, Carlo Chezzi, Giuseppe Dettori.   

Abstract

The new Vidia system is a fully automated system based on chemiluminescence and antigen bound to magnetic microparticles, which allows a fast measurement of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM levels. The analytical performances of the Vidia Toxo IgG and IgM assays were compared with those of the automated Vidas, AxSYM, and Liaison Toxo IgG and IgM assays. The comparative evaluation was performed utilizing 204 frozen sera belonging to 166 subjects and 201 fresh sera collected from 198 subjects. For the Vidia Toxo IgG system, the sensitivities were 100% in both the retrospective and prospective studies, and specificities were 98.39% in the retrospective study and 100% in the prospective study, respectively. The sensitivities of the other three Toxo IgG assays were 100%, and the specificities ranged from 96.77% to 100%. For the Vidia Toxo IgM assay, the sensitivity and specificity were 100% in both the retrospective and prospective studies. The overall sensitivities and specificities of the other three Toxo IgM assays ranged from 80% to 100% and from 99.44% to 100%, respectively. In our study, the Vidia system revealed excellent sensitivity (100% for both IgG and IgM assays) and good specificity (99.25% for IgG and 100% for IgM assays).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480234      PMCID: PMC2446631          DOI: 10.1128/CVI.00025-08

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  13 in total

1.  Antenatal screening for hepatitis B and antibodies to Toxoplasma gondii and rubella virus: evaluation of two commercial immunoassay systems.

Authors:  R J Diepersloot; H Dunnewold-Hoekstra; J Kruit-Den Hollander; F Vlaspolder
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

Review 2.  Recent developments for diagnosis of toxoplasmosis.

Authors:  Jack S Remington; Philippe Thulliez; Jose G Montoya
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Comparison between two real-time PCR assays and a nested-PCR for the detection of Toxoplasma gondii.

Authors:  Adriana Calderaro; Giovanna Piccolo; Chiara Gorrini; Simona Peruzzi; Laura Zerbini; Simona Bommezzadri; Giuseppe Dettori; Carla Chezzi
Journal:  Acta Biomed       Date:  2006-08

4.  Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.

Authors:  P A Jenum; B Stray-Pedersen
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems.

Authors:  W T Hofgärtner; S R Swanzy; R M Bacina; J Condon; M Gupta; P E Matlock; D L Bergeron; J J Plorde; T R Fritsche
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

6.  Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies.

Authors:  J M Pinon; H Dumon; C Chemla; J Franck; E Petersen; M Lebech; J Zufferey; M H Bessieres; P Marty; R Holliman; J Johnson; V Luyasu; B Lecolier; E Guy; D H Joynson; A Decoster; G Enders; H Pelloux; E Candolfi
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

7.  Evaluation of serological markers for the immunodiagnosis of acute acquired toxoplasmosis.

Authors:  Lisandra A Suzuki; Rosângela J Rocha; Cláudio L Rossi
Journal:  J Med Microbiol       Date:  2001-01       Impact factor: 2.472

Review 8.  Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis.

Authors:  Jose G Montoya
Journal:  J Infect Dis       Date:  2002-02-15       Impact factor: 5.226

9.  Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group.

Authors:  I Villena; D Aubert; B Leroux; D Dupouy; M Talmud; C Chemla; T Trenque; G Schmit; C Quereux; M Guenounou; M Pluot; A Bonhomme; J M Pinon
Journal:  Scand J Infect Dis       Date:  1998

10.  Comparison of two commercially available avidity tests for toxoplasma-specific IgG antibodies.

Authors:  Cosme Alvarado-Esquivel; Shneh Sethi; Klaus Janitschke; Helmut Hahn; Oliver Liesenfeld
Journal:  Arch Med Res       Date:  2002 Nov-Dec       Impact factor: 2.235

View more
  10 in total

1.  Evaluation of the new Elecsys Toxo IgG avidity assay for toxoplasmosis and new insights into the interpretation of avidity results.

Authors:  Jean-Benjamin Murat; Coralie L'Ollivier; Hélène Fricker Hidalgo; Jacqueline Franck; Hervé Pelloux; Renaud Piarroux
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

2.  Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns.

Authors:  Jean-Benjamin Murat; Céline Dard; Hélène Fricker Hidalgo; Marie-Laure Dardé; Marie-Pierre Brenier-Pinchart; Hervé Pelloux
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

3.  Endothelial dysfunction in acute acquired toxoplasmosis.

Authors:  Azhar H Al-Kuraishi; Salah D Al-Windy; Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  Trop Parasitol       Date:  2020-05-20

4.  Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study.

Authors:  H Fricker-Hidalgo; B Cimon; C Chemla; M L Darde; L Delhaes; C L'ollivier; N Godineau; S Houze; L Paris; D Quinio; F Robert-Gangneux; O Villard; I Villena; E Candolfi; H Pelloux
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

5.  Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

Authors:  Eileen Stillwaggon; Christopher S Carrier; Mari Sautter; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27

6.  Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women.

Authors:  Aurélie Smets; Thomas Fauchier; Grégory Michel; Pierre Marty; Christelle Pomares
Journal:  Parasite       Date:  2016-10-20       Impact factor: 3.000

7.  Seroprevalence of Toxoplasma gondii in pregnant women and livestock in the mainland of China: a systematic review and hierarchical meta-analysis.

Authors:  Huifang Deng; Brecht Devleesschauwer; Mingyuan Liu; Jianhua Li; Yongning Wu; Joke W B van der Giessen; Marieke Opsteegh
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

8.  Seroepidemiology of Toxoplasma gondii infection in the Israeli population.

Authors:  M Perry Markovich; T Shohat; I Riklis; R Avni; D Yujelevski-Rozenblit; R Bassal; D Cohen; E Rorman
Journal:  Epidemiol Infect       Date:  2013-04-15       Impact factor: 4.434

9.  Laboratory diagnosis of Toxoplasma gondii infection.

Authors:  A Calderaro; S Peruzzi; G Piccolo; C Gorrini; S Montecchini; S Rossi; C Chezzi; G Dettori
Journal:  Int J Med Sci       Date:  2009-03-19       Impact factor: 3.738

10.  Primary Ocular Toxoplasmosis Presenting to Uveitis Services in a Non-endemic Setting.

Authors:  Riyaz Bhikoo; Erika M Damato; Stephen Guest; Jo Sims
Journal:  Korean J Ophthalmol       Date:  2019-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.